Telogen Effluvium Following the Treatment of Euglycemic Diabetic Ketoacidosis in a Patient With Heavy Soft Drink Intake: A Case Report

    October 2024 in “ Cureus
    Yuta Yoshino, Maho Hayashi
    Image
    Studysummary This case report explores a 28-year-old man with type 2 diabetes who experienced telogen effluvium, a type of hair loss, following treatment for euglycemic diabetic ketoacidosis with luseogliflozin, possibly triggered by physical stress related to his condition and treatment. Our plain-language summary of this paper — not a Tressless recommendation.
    This case report describes a 28-year-old man with type 2 diabetes mellitus, linked to heavy soft drink consumption, who developed telogen effluvium after treatment for euglycemic diabetic ketoacidosis with luseogliflozin. The patient experienced significant hair loss two months post-discharge, which lasted for three months. The hair loss was attributed to physical wasting from hyperglycemia and ketoacidosis, compounded by rapid weight loss. The case highlights the importance of identifying triggers for telogen effluvium, which often occur two to three months before hair loss onset, and emphasizes the need for psychological support due to the impact of hair loss on quality of life.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results